UBS Group’s Salarius Pharmaceuticals SLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.3K | Sell |
|
|||||
|
2025
Q1 | $25.5K | Buy |
|
|||||
|
2024
Q4 | $13K | Buy |
|
|||||
|
2024
Q3 | $375 | Buy |
|
|||||
|
2024
Q2 | $269 | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $51 | Hold |
|
|||||
|
2023
Q3 | $51 | Hold |
|
|||||
|
2023
Q2 | $116 | Sell |
|
|||||
|
2023
Q1 | $2.15K | Buy |
|
|||||
|
2022
Q4 | $366 | Sell |
|
|||||
|
2022
Q3 | $8K | Hold |
|
|||||
|
2022
Q2 | $9K | Buy |
|
|||||
|
2022
Q1 | $1K | Hold |
|
|||||
|
2021
Q4 | $1K | Sell |
|
|||||
|
2021
Q3 | $7K | Hold |
|
|||||
|
2021
Q2 | $7K | Sell |
|
|||||
|
2021
Q1 | $19K | Buy |
|
|||||
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $8K | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $17K | Buy |
|
|||||
|
2019
Q2 | – | Hold |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $13K | Buy |
|
|||||
|
2018
Q3 | – | Hold |
|
|||||
|
2018
Q2 | – | Hold |
|
|||||
|
2018
Q1 | – | Hold |
|
|||||
|
2017
Q4 | – | Hold |
|
|||||
|
2017
Q3 | – | Hold |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Hold |
|
|||||
|
2016
Q4 | – | Hold |
|
|||||
|
2016
Q3 | – | Hold |
|
|||||
|
2016
Q2 | – | Hold |
|
|||||
|
2016
Q1 | – | Hold |
|
|||||
|
2015
Q4 | – | Hold |
|
|||||
|
2015
Q3 | – | Hold |
|
|||||
|
2015
Q2 | – | Hold |
|
|||||
|
2015
Q1 | – | Hold |
|